
South Korea's Samsung BioLogics says it plans to separate company
SEOUL :South Korea's Samsung BioLogics said on Thursday it plans to separate the company between its drug contract manufacturing business, and a business overseeing subsidiaries including biosimilar drug developer Samsung Bioepis as well as new …